Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Diamond

Showing results (831-840 of 1,229) with videos related to

Pageof 123
Sort By:
Cell Reports|November 9, 2017
An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon ResponsesAaron F Carlin, Emily M Plummer, Edward A Vizcarra, et al.
Clinical Chemistry|September 7, 2020
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological AssaysMei San Tang, James Brett Case, Caroline E Franks, et al.
Cell Host & Microbe|November 5, 2020
Accelerated Preclinical Paths to Support Rapid Development of COVID-19 TherapeuticsJay A Grobler, Annaliesa S Anderson, Prabhavathi Fernandes, et al.
Journal of Virology|October 16, 2015
Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous SystemJose Luiz Proenca-Modena, Jennifer L Hyde, Renata Sesti-Costa, et al.
Neuro-Oncology|February 23, 2026
Oncolytic Zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responsesKevin S Cashman, Akshitkumar M Mistry, Ashwani Kesarwani, et al.
Mbio|September 17, 2015
Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus InfectionAmelia K Pinto, James D Brien, Chia-Ying Kao Lam, et al.
Journal of Virology|October 20, 2021
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In MiceEmma S Winkler, Rita E Chen, Fahmida Alam, et al.
Inflammatory Bowel Diseases|December 1, 2021
Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in MiceDavid M Alvarado, Juhee Son, Larissa B Thackray, et al.
Virology|December 6, 2005
A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infectionTheodore C Pierson, Melissa D Sánchez, Bridget A Puffer, et al.
Cell Reports|September 5, 2019
Expression of the Mxra8 Receptor Promotes Alphavirus Infection and Pathogenesis in Mice and DrosophilaRong Zhang, James T Earnest, Arthur S Kim, et al.
Pageof 123

Showing results (831-840 of 1,229) with videos related to

Sort By:
Pageof 123
Cell Reports|November 9, 2017
An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon ResponsesAaron F Carlin, Emily M Plummer, Edward A Vizcarra, et al.
Clinical Chemistry|September 7, 2020
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological AssaysMei San Tang, James Brett Case, Caroline E Franks, et al.
Cell Host & Microbe|November 5, 2020
Accelerated Preclinical Paths to Support Rapid Development of COVID-19 TherapeuticsJay A Grobler, Annaliesa S Anderson, Prabhavathi Fernandes, et al.
Journal of Virology|October 16, 2015
Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous SystemJose Luiz Proenca-Modena, Jennifer L Hyde, Renata Sesti-Costa, et al.
Neuro-Oncology|February 23, 2026
Oncolytic Zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responsesKevin S Cashman, Akshitkumar M Mistry, Ashwani Kesarwani, et al.
Mbio|September 17, 2015
Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus InfectionAmelia K Pinto, James D Brien, Chia-Ying Kao Lam, et al.
Journal of Virology|October 20, 2021
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In MiceEmma S Winkler, Rita E Chen, Fahmida Alam, et al.
Inflammatory Bowel Diseases|December 1, 2021
Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in MiceDavid M Alvarado, Juhee Son, Larissa B Thackray, et al.
Virology|December 6, 2005
A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infectionTheodore C Pierson, Melissa D Sánchez, Bridget A Puffer, et al.
Cell Reports|September 5, 2019
Expression of the Mxra8 Receptor Promotes Alphavirus Infection and Pathogenesis in Mice and DrosophilaRong Zhang, James T Earnest, Arthur S Kim, et al.
Pageof 123